Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients
Authors:
- Stephen P. DunnSDStephen P. Dunn
- Beth RymeskiBRBeth Rymeski
- James MalatackJMJames Malatack
- Nancy H. RongNRNancy H. Rong
- Louise FlynnLFLouise Flynn
- Leslie J. KruegerLKLeslie J. Krueger
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 43 (6) , 1134-1141
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCRBreast Cancer Research, 2006
- Sustained Epstein-Barr Virus Detection in Paediatric Liver Transplantation. Insights Into the Occurrence of Late PTLDLiver Transplantation, 2006
- Monitoring immune function during tacrolimus tapering in small bowel transplant recipientsTransplant Immunology, 2005
- Establishing pediatric immune response zones using the Cylex® ImmuKnowTM assayClinical Transplantation, 2005
- Statistical Process Control and Calcineurin Inhibitor ManagementThe Journal of Pediatrics, 2005
- A Novel Approach to Managing Variation: Outpatient Therapeutic Monitoring of Calcineurin Inhibitor Blood Levels in Liver Transplant RecipientsThe Journal of Pediatrics, 2005
- Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient managementClinical Transplantation, 2003
- Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantationPediatric Transplantation, 2002
- The Impact of Immunosuppressive Drugs on the Analysis of T-Cell ActivationCurrent Medicinal Chemistry, 2000
- TacrolimusDrugs, 1997